Welcome to Genmab

Engineering a
transformative tomorrow

As a leading international biotechnology company, we believe in the transformative power of science and technology. Science is not only our bedrock, it is our inspiration. We believe in improving the lives of patients with cancer by creating and developing innovative and differentiated antibody therapeutics that will transform the future of cancer treatment. We are Genmab.

Learn more

Pipeline

Transforming the future of cancer treatment

Cancer presents constant challenges in our society—from advancing drug development to fulfilling the unmet medical needs of patients. At Genmab, we have an appreciation for the power of the human immune system that gives us a unique perspective on how to respond and find solutions. That’s why we are focused on harnessing the immune system’s natural ability to fight against diseases to create therapeutics that have the potential to transform how cancer is treated.

See our products

Our Technology Platforms

Pioneering the next generation of antibody platforms

With an in-depth knowledge of antibody biology, we discover, develop and select the best possible antibody products. This relentless drive to innovate and advance the process of antibody discovery has led to our proprietary antibody technologies.

See our science at work

LATEST NEWS

Genmab published its Financial Results for the First Half of 2022 and unveils 2030 vision

Today, Genmab published its interim report for the first half of the year 2022 and unveiled its aspiration for its future with a new vision that by 2030, it will develop knock-your-socks-off “KYSO” antibody medicines to fundamentally transform the lives of people with cancer and other serious diseases.

Read Report

View Presentation

We turn science into medicine. We use our deep antibody expertise to create cancer therapeutics with the potential to improve patients’ lives.

Load more

Genmab’s First Half 2022 Financial Results

On Aug 10, Genmab announced financial results for the first six months of 2022.

View Report | Download Presentation | Listen to Webcast

Join our mission to transform the future of cancer treatment.

Learn about career opportunities

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.